JP2004526737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526737A5 JP2004526737A5 JP2002576627A JP2002576627A JP2004526737A5 JP 2004526737 A5 JP2004526737 A5 JP 2004526737A5 JP 2002576627 A JP2002576627 A JP 2002576627A JP 2002576627 A JP2002576627 A JP 2002576627A JP 2004526737 A5 JP2004526737 A5 JP 2004526737A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- compound according
- oligonucleotide
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 19
- 108091034117 Oligonucleotide Proteins 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 108010017842 Telomerase Proteins 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 108010057210 telomerase RNA Proteins 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- YACKEPLHDIMKIO-UHFFFAOYSA-L methylphosphonate(2-) Chemical compound CP([O-])([O-])=O YACKEPLHDIMKIO-UHFFFAOYSA-L 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000004713 phosphodiesters Chemical class 0.000 claims 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27832201P | 2001-03-23 | 2001-03-23 | |
| US60/278,322 | 2001-03-23 | ||
| PCT/US2002/009138 WO2002077184A2 (en) | 2001-03-23 | 2002-03-21 | Oligonucleotide conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004526737A JP2004526737A (ja) | 2004-09-02 |
| JP2004526737A5 true JP2004526737A5 (enExample) | 2005-12-22 |
| JP4854913B2 JP4854913B2 (ja) | 2012-01-18 |
Family
ID=23064542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002576627A Expired - Lifetime JP4854913B2 (ja) | 2001-03-23 | 2002-03-21 | オリゴヌクレオチド結合体 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1379689B1 (enExample) |
| JP (1) | JP4854913B2 (enExample) |
| AU (1) | AU2002245717A1 (enExample) |
| CA (1) | CA2440322C (enExample) |
| WO (1) | WO2002077184A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563618B2 (en) | 2001-03-23 | 2009-07-21 | Geron Corporation | Oligonucleotide conjugates |
| JP4690324B2 (ja) | 2003-09-09 | 2011-06-01 | ジェロン・コーポレーション | テロメラーゼ阻害のための改変オリゴヌクレオチド |
| TW200540180A (en) * | 2004-05-28 | 2005-12-16 | Sankyo Co | Telomerase inhibitor ena oligonucleotide |
| RS56361B1 (sr) | 2004-07-02 | 2017-12-29 | Geron Corp | Sinteza zaštićenih 3'-amino nukleozidnih monomera |
| US9228189B2 (en) | 2012-10-26 | 2016-01-05 | Geron Corporation | C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders |
| US9200327B2 (en) | 2012-11-30 | 2015-12-01 | Geron Corporation | Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors |
| US9375485B2 (en) | 2012-12-07 | 2016-06-28 | Geron Corporation | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms |
| CA2925500C (en) | 2013-09-30 | 2023-03-14 | Geron Corporation | Phosphorodiamidate backbone linkage for oligonucleotides |
| JOP20200257A1 (ar) * | 2014-05-01 | 2017-06-16 | Geron Corp | تركيبات أوليجو نوكليوتيد وطرق لتحضيرها |
| MA42569B1 (fr) | 2015-04-23 | 2020-08-31 | Geron Corp | Procédés de préparation de polynucléotides à l'aide de compositions de sel cationique multivalent |
| TWI879717B (zh) | 2017-07-28 | 2025-04-11 | 美商傑龍公司 | 治療骨髓增生不良症候群之方法 |
| SG11202105573PA (en) | 2018-11-29 | 2021-06-29 | Geron Corp | Methods of treating myelodysplastic syndrome |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965349A (en) * | 1987-12-24 | 1990-10-23 | Applied Biosystems, Inc. | Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports |
| US5352803A (en) * | 1992-03-30 | 1994-10-04 | Abbott Laboratories | 5(6)-methyl substituted fluorescein derivatives |
| US5863726A (en) * | 1993-11-12 | 1999-01-26 | Geron Corporation | Telomerase activity assays |
| JP3189000B2 (ja) * | 1994-12-01 | 2001-07-16 | 東ソー株式会社 | 特定核酸配列の検出方法 |
| US6425604B1 (en) * | 1999-02-23 | 2002-07-30 | Recreational Technologies International, Llc | Vehicle leveling assembly |
| AU767646B2 (en) * | 1999-09-10 | 2003-11-20 | Geron Corporation | Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
-
2002
- 2002-03-21 WO PCT/US2002/009138 patent/WO2002077184A2/en not_active Ceased
- 2002-03-21 CA CA2440322A patent/CA2440322C/en not_active Expired - Lifetime
- 2002-03-21 AU AU2002245717A patent/AU2002245717A1/en not_active Abandoned
- 2002-03-21 JP JP2002576627A patent/JP4854913B2/ja not_active Expired - Lifetime
- 2002-03-21 EP EP02713894A patent/EP1379689B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007504830A5 (enExample) | ||
| JP2011092201A5 (enExample) | ||
| JP2004526737A5 (enExample) | ||
| JP2009524696A5 (enExample) | ||
| TW202018081A (zh) | 用於B型肝炎病毒感染之RNAi藥劑 | |
| CN100400045C (zh) | 基于核酸的化合物及其使用方法 | |
| JP7348922B2 (ja) | Ｂ型肝炎感染の治療用のＰＡＰＤ５及びＰＡＰＤ７ ｍＲＮＡを低減させるための核酸分子 | |
| JP2019512498A (ja) | Ｐｄ−ｌ１発現低減用のオリゴヌクレオチド | |
| JP2018521970A (ja) | ペプチドオリゴヌクレオチドコンジュゲート | |
| JP2006518197A5 (enExample) | ||
| US20020160969A1 (en) | Nucleosides and oligonucleotides containing boron clusters | |
| BRPI0717510A2 (pt) | Análogos de oligonucleotídeo cpg contendo análogos t hidrofóbicos com atividade imunoestimulatória intensificada | |
| JP2005532287A5 (enExample) | ||
| JP2003523739A5 (enExample) | ||
| JP2004528809A5 (enExample) | ||
| JP2007505627A5 (enExample) | ||
| JP2012050438A5 (enExample) | ||
| JP2011506274A5 (enExample) | ||
| JP2005525991A5 (enExample) | ||
| JP2019525918A5 (enExample) | ||
| JP2021506246A5 (enExample) | ||
| ES2901772T3 (es) | Conjugados de péptido oligonucleótido | |
| JP2021072862A5 (enExample) | ||
| JP2006502243A5 (enExample) | ||
| JP2013537404A5 (enExample) |